APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -57.9% | 419 | 0.0% | 0.00% | – |
| Q2 2023 | $38 | +31.0% | 419 | -5.8% | 0.00% | – |
| Q1 2023 | $29 | +26.1% | 445 | 0.0% | 0.00% | – |
| Q4 2022 | $23 | -99.9% | 445 | +12.1% | 0.00% | – |
| Q3 2022 | $27,000 | +50.0% | 397 | 0.0% | 0.00% | – |
| Q2 2022 | $18,000 | +20.0% | 397 | +33.2% | 0.00% | – |
| Q1 2022 | $15,000 | +7.1% | 298 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | +40.0% | 298 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | 0.0% | 298 | +87.4% | 0.00% | – |
| Q2 2021 | $10,000 | +42.9% | 159 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | -12.5% | 159 | +12.0% | 0.00% | – |
| Q4 2020 | $8,000 | -38.5% | 142 | -66.1% | 0.00% | – |
| Q3 2020 | $13,000 | +18.2% | 419 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | 0.0% | 419 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | 0.0% | 419 | +16.1% | 0.00% | – |
| Q4 2019 | $11,000 | +10.0% | 361 | -9.3% | 0.00% | – |
| Q3 2019 | $10,000 | 0.0% | 398 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | +42.9% | 398 | +11.2% | 0.00% | – |
| Q1 2019 | $7,000 | 0.0% | 358 | -28.4% | 0.00% | – |
| Q4 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |